Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 44.72M | $ 25K | 0.06% |
3/31/2025 | $ 56.42M | $ 63K | 0.11% |
12/31/2024 | $ 66.91M | $ 99K | 0.15% |
9/30/2024 | $ 76.2M | $ 123K | 0.16% |
6/30/2024 | $ 86.65M | $ 145K | 0.17% |
3/31/2024 | $ 91.68M | $ 180K | 0.2% |
12/31/2023 | $ 97.69M | $ 214K | 0.22% |
9/30/2023 | $ 19.27M | $ 0 | 0% |
6/30/2023 | $ 24.96M | $ 0 | 0% |
3/31/2023 | $ 35.26M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for VYNE THERAPEUTICS INC is calculated as follows: Debt [ $ 35.21M ] / Assets [ $ 107.68M ]
(=) Debt to Assets [ 32.7% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 4.37K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.09% |
std | 24.49% |